Cathy Eng
机构:Vanderbilt University, Tennessee Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center · ORCID:0000-0003-2335-0612
发表论文 826 篇 · 总被引 27443 次 · h-index 77
代表论文
- Early‐Onset Gastric Cancer as a High‐Risk Disease Entity in the United States: Clinicopathologic Features, Regional Variation, and Outcomes (2026 · Cancer Medicine)
- Figure S8 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer (2026)
- Supplementary Figure S4 from Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal (2026)
- Table S3 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer (2026)
- Supplementary Table S1 from Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal (2026)
- Table S5 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer (2026)